KMK insights
Updates, expertise, and point-of-view on pharmaceutical commercial operations, sales analytics, data management, market research, and sales force effectiveness.
Unique Patient Simulation App to Explore Treatment for Rare Disease
To prepare for the launch of a novel therapy, our client needed to better understand the treatment algorithm for a rare disease condition. Our mid-size specialty pharmaceutical client needed to understand the treatment algorithm for a rare disease condition in...
Leverage Anonymized Patient Level Data (APLD) to Identify Market Opportunities
How can you use patient level data to help rebound from a sluggish product launch?Our client, a growing specialty pharmaceutical company, has a new product approved for treating two different diseases. After a year on the market, however, the new drug’s uptake is not...
![[Webinar Invite] Weathering the COVID-19 Storm: Incorporating Beliefs, Knowledge, and Research to Boost Confidence in Pharmaceutical Sales Forecasting](https://kmkconsultinginc.com/wp-content/uploads/2019/10/kmk-consulting_home_slider-2-c-400x250.jpg)
[Webinar Invite] Weathering the COVID-19 Storm: Incorporating Beliefs, Knowledge, and Research to Boost Confidence in Pharmaceutical Sales Forecasting
Weathering the COVID-19 Storm: Incorporating Beliefs, Knowledge, and Research to Boost Confidence in Pharmaceutical Sales Forecasting In this webinar, KMK Consulting, Inc. will share real-world approaches to forecasting and market research to more accurately predict...
HEOR Principal Huanxue Zhou’s Manuscript in International Journal of MS Care
KMK HEOR Principal Huanxue Zhou's latest manuscript has been published. The title of the article is Impact of Switching to Fingolimod Versus Injectable Disease-Modifying Therapy Cycling on Risk of Multiple Sclerosis-Related Relapses. A PDF of the article is available...
Real World Evidence to Support Payer Negotiation
How do you prove a product's value to negotiate pricing with a payer? Our client, a large global pharmaceutical company, was facing a market access problem for their newly launched product. Generic treatments have been widely available for many years in this...
What Innovations are Oncologists Looking Forward to in Breast Cancer Therapy?
KMK Consulting’s Innovation and Customer Value Survey in breast cancer explores oncologists’ perspectives on the innovations they are looking forward to in the next two years, and the companies they see as best positioned to deliver them. To learn more view the...
What are the most important asthma products and what makes them superior?
KMK Consulting’s recent Innovation and Customer Value Survey in asthma explores pulmonologist perspectives on the most important new asthma therapies introduced in the past two years, the innovations they are looking forward to in the next two years, and the companies...
High Cost of Medication Tops the List of Challenges for Gastroenterologists Treating IBS
Gastroenterologists cited a range of challenges treating IBS in KMK's recent Innovation & Customer Value Survey. Topping the list were the high cost of medication and patient education and understanding of the disease. Concurrently, the study found that support...
How to Reach Oncologists when Face-to-Face Interaction is Impossible
How do you reach oncologists when face-to-face interaction is no longer an option? Which social media channels are doctors using to gather medical information? In KMK's Customer Value and Innovation Study we learned that oncologists working in breast cancer can be...
